Skip to main content

Advertisement

Log in

A case report of advanced male breast cancer with an objective response to tamoxifen treatment

  • Case Report
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

A 70-year-old man presented with a firm tumor in his right breast first noticed eight years ago. The tumor had enlarged gradually and had produced an ulcer with bleeding. On physical examination, a huge tumor entirely occupied the right breast and extensively had infiltrated the chest wall. Chest X-ray and CT showed massive pleural effusion and multiple small nodular lesions in the lung. Invasive ductal carcinoma of the breast was diagnosed by incisional biopsy, confirming advanced breast cancer with lung metastases and bilateral pleural effusion (T4cN2Ml, Stage IV). Because ER and PgR levels were 110 fmol/mg and 190 fmol/mg, respectively, and because his general condition was poor, we selected medical treatment with tamoxifen (TAM). Thirty-two weeks later, the tumor had showed pronounced reduction with scarring. The patient underwent local excision of the scar tissue. The quality of life of the patient was favorably improved and no severe adverse events were observed. The tumor in the chest wall recurred two months after the end of TAM treatment, possibly because the patient did not accept continuous TAM therapy. The patient died from complications of brain metastasis 32 months after the start of TAM treatment. We report a rare case of advanced male breast cancer and on the effectiveness of continuous TAM treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

TAM:

Tamoxifen

ER:

Estrogen receptor

PgR:

Progesterone receptor

References

  1. Crichlow RW: Carcinoma of the male breast.Surg Gynecol Obstet 134:1011–1019, 1972.

    PubMed  CAS  Google Scholar 

  2. Ciatto S, Iossa A, Bonardi R: Male breast carci- noma:Review of a multicenter series of 150cases.Tumori 76:555–558, 1990.

    PubMed  CAS  Google Scholar 

  3. Bogen PI, Wong GY, Vlamis V: Current management of male breast cancer.Ann Surg 215:451–457, 1992.

    Article  Google Scholar 

  4. Guinee VF, Olsson H, Moller T,et al: The prognosis of breast cancer in males.Cancer 71:154–161, 1993.

    Article  PubMed  CAS  Google Scholar 

  5. Moseley HS, Fletcher WS, Leung BS,et al: Predictive criteria for the selection of breast cancer patients for adrenalectomy.Am J Surg 128:143–151, 1974.

    Article  PubMed  CAS  Google Scholar 

  6. Everson RB, Lippmann ME, Thonpson EB,et al: Clinical correlations of steroid receptors and male breast cancer.Cancer Res 40:991–997, 1980.

    PubMed  CAS  Google Scholar 

  7. Gupta N, Cohen JL, Rosenbaum C,et al: Estrogen receptors in male cancer.Cancer46:1781–1784, 1980.

    Article  PubMed  CAS  Google Scholar 

  8. Friedman MA, Hoffman PG, Dandolos EM,et al: Estrogen receptors in male breast cancenclinical and pathologic correlations.Cancer 47:134–137, 1981.

    Article  PubMed  CAS  Google Scholar 

  9. Cantwell BMJ, Tong D, Minton M,et al: Tamoxifen and male breast cancer.Lancet 2:582–583, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. Morgan DAL, Hong A: Carcinoma of the male breast and oestrogen metabolism.Br Med 12:206, 1978.

    Google Scholar 

  11. Abele R, Alberto P, Megevand R: Carcinoma of the male breast and oestrogen metabolism.Br Med J 1:1697–1698, 1978.

    Article  Google Scholar 

  12. Aisner J, Ross DD, Wiernik PH: Tamoxifen in advanced male breast cancer.Arch Intern Med 139:480–481, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Patterson JS, Battersby LA, Bach BK: Use of tamoxien in advanced male breast cancer.Cancer Treat Rep 64:801–804, 1980.

    PubMed  CAS  Google Scholar 

  14. Rebeiro GG, Swindell R: Adjuvant tamoxifen for male breast cancer (MBC).Br J Cancer 65:252–254, 1992.

    Google Scholar 

  15. Becher R, Hoffken K, Pape H,et al: Tamoxifen treatment before orchiectomy in advanced breast cancer in men.New Engl J Med 305:169, 1981.

    PubMed  CAS  Google Scholar 

  16. Tirelli U, Tumolo S, Talamini R,et al: Tamoxifen before and orchiectomy in advanced male breast cancer.Cancer Treast Rep 66:1882–1883, 1982.

    CAS  Google Scholar 

  17. Ribeiro GG: Tamoxifen in treatment of male breast carcinoma.Clin Radiol 34:625–628, 1983.

    Article  PubMed  CAS  Google Scholar 

  18. Anelli MTF, Anelli A, Tran KN,et al: Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients.Cancer 74:74–77, 1994.

    Article  PubMed  CAS  Google Scholar 

  19. Kraybill WG, Kaufman R, Kinne D: Treatment of advanced male breast cancer.Cancer47:2185–2189, 1981.

    Article  PubMed  CAS  Google Scholar 

  20. Pannuti F, Martoni A, Busutti L,et al: High-dose medroxy-progesterone acetate in advanced male breast cancer.Cancer Treat Rep 66:1763–1765, 1982.

    PubMed  CAS  Google Scholar 

  21. Bezwoda WR, Hesdorffer C, Dansey R,et al: Breast cancer in men. Clinical features, hormone receptor status, and response to therapy.Cancer60:1337–1340, 1987.

    Article  PubMed  CAS  Google Scholar 

  22. Doberauer C, Niederle N, Schmidt CG,et al: Advanced male breast cancer treatment with the LH- RH analogue buserelin alone or in combination with the antiandrogene flutamide.Cancer72:474–478, 1988.

    Article  Google Scholar 

  23. Lopez M, Natali M, Lauro LD,et al: Combined treatment with buserelin and cyproterone acetate in matastatic male breast cancer.Cancer72:502–505, 1993.

    Article  PubMed  CAS  Google Scholar 

  24. Sasano H, Kimura M, Shizawa S,et al: Aromatase and steroid receptors in gynecomastia and male breast carcinoma:an immunohistochemical study.J Clin Endocrino Metab81:3063–3067, 1996.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Kanoh, T., lino, Y., Horiguchi, J. et al. A case report of advanced male breast cancer with an objective response to tamoxifen treatment. Breast Cancer 7, 256–260 (2000). https://doi.org/10.1007/BF02967470

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967470

Key words

Navigation